5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Syngene International Ltd.

•
syngeneintl.comBSE: 539268NSE: SYNGENE
Market Cap₹ 15,446 Cr.
Current Price
High / Low₹ 679 / 375
Stock P/E67.5
Book Value₹ 115
Price to Book3.37
Dividend Yield0.33 %
ROCE8.9 %
ROE6.6 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.31x)
  • Working capital cycle has improved - days down from 76 to 49
  • Company generates healthy free cash flow
  • Company has a consistent dividend-paying track record

CONS

  • Recent results are weak - TTM profit is down 54.8% versus prior year
  • Company has a low return on equity of 9.8% over last 3 years
  • Promoter holding has decreased over last 2 years: -2.1pp
  • Company has delivered a poor profit growth of -5.5% over past five years
  • Operating margins have contracted to 23.5% from 31.4%
  • Recurring exceptional / one-off items are inflating headline profit

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareBusiness ServicesBusiness Support
Part ofNIFTY TOTAL MKTNIFTY SMLCAP 50NIFTY 500NIFTY SMLCAP 250NIFTY HEALTHCARE
S.No.Name
1.PFOCUS310.60209.2824188.720.00-457.78-514.4312668.151196.882.7423.76
2.SAGILITY45.1521.2821136.200.33216.8145.941963.4827.5913.8222.32
3.HORIZONIND55.65244.0316043.350.00-116.27—2005.46—3.3280.26
4.SYNGENE382.6569.8915446.400.33-9.00-110.38736.00-15.849.4812.34
5.INDGN578.0534.7413929.080.39116.20-0.171063.1039.7318.9216.39
6.IGIL314.2022.2713578.461.59165.7430.98370.7823.2277.0060.35
7.NESCO1102.7518.657769.970.6399.963.97211.809.5519.2348.33
8.LEAPIND144.55102.156367.950.00247.33—2034.13—9.3251.19
9.SPARC196.104.026363.870.00-20.7859.9439.92314.11163.94-85.17
10.SMARTWORKS530.60217.746069.060.0013.15413.27546.2544.0561.1263.33
11.JUSTDIAL665.1015.595656.610.00115.7438.44270.2716.2312.8826.17
12.LATENTVIEW252.5026.765228.850.0047.10-6.84286.8821.5516.6919.76
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
716831792865726821877948799830834960663
552614592565578613627638631653650676684
Operating Profit163217200299148209250310168178185284-21
OPM %22.83%26.07%25.19%34.61%20.40%25.40%28.47%32.69%21.03%21.38%22.14%29.61%-3.21%
23142515501619181714-511438
Interest69687771067664
Depreciation899194969294929095100979596
Profit before Tax9213112521099124170229848430197-10
Tax %17.70%22.26%19.97%9.79%25.20%22.28%27.50%23.74%12.11%21.38%45.18%24.66%79.00%
Net Profit751021001907497123174746616148-2
1.882.532.494.731.842.413.074.341.841.650.413.68-0.05

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
1,2011,4231,8262,0122,1792,6013,1943,2033,3733,4243,288
8161,0331,2911,4101,5281,8642,2612,3242,4562,6152,662
Operating Profit385390534602651738933879918809625
OPM %32.03%27.41%29.28%29.93%29.88%28.36%29.20%27.43%27.20%23.63%19.02%
9413676167118787377102-115
Interest1823323528244530312624
Depreciation114131164219274310359369367387388
Profit before Tax346372414516467482601557622395301
Tax %17.09%18.01%20.16%20.21%13.63%18.25%21.28%16.29%24.71%22.85%23.99%
Net Profit287305331412404394473466468305229
EPS14.5515.418.3410.3310.08977.0011.7211.6011.637.57—
Dividend Payout %6.96%6.56%3.02%0.00%0.00%10.18%10.61%10.77%10.75%16.52%—

COMPOUNDED SALES GROWTH

10 Years:
12%
5 Years:
9%
3 Years:
2%

COMPOUNDED PROFIT GROWTH

10 Years:
2%
5 Years:
-5%
3 Years:
-14%

STOCK PRICE CAGR

10 Years:
5%
5 Years:
-10%
3 Years:
-23%
1 Year:
-42%

RETURN ON EQUITY

10 Years:
16%
5 Years:
11%
3 Years:
10%
Last Year:
7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Jun 25

₹ 0.12

Rs.1.2500 per share(12.5%)Final Dividend

2025

Jun 27

₹ 0.12

Rs.1.2500 per share(12.5%)Final Dividend

2024

Jun 28

₹ 0.12

Rs.1.2500 per share(12.5%)Final Dividend

2023

Jun 30

₹ 0.07

Rs.0.7500 per share(7.5%)Special Dividend

2023

Jun 30

₹ 0.05

2022

Jun 30

₹ 0.05

Rs.0.5000 per share(5%)Final Dividend

2022

Jun 30

₹ 0.05

19/08/2022 Equity Rs.0.5000 per share(5%)Special Dividend

2018

Jul 17

₹ 0.10

Rs.1.0000 per share(10%)Final Dividend

2017

Jul 20

₹ 0.10

03/08/2017 Equity Rs.1.0000 per share(10%)Final Dividend

2016

Mar 17

₹ 0.10

31/03/2016 Equity Interim Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital200200200400400401401402402403
1,1881,4921,7391,7352,3412,8043,1553,7724,2094,259
8848761,0301,0951,1411,261904547502422
Trade Payables102203224223239235260254346310
3363454195866677941,0478099181,085
Total Liabilities2,7113,1163,6114,0394,7895,4965,7685,7846,3776,479
8101,0301,3371,9842,1632,3542,2122,2772,2072,456
Capital Work in Progress175155274234237346126758875536
5401587167777021,0349419281,4681,564
3286432560179333234150137
0000000428469432
Cash & Bank527966435280638515509528652724
6267208057399881,0661,647632554630
Total Assets2,7113,1163,6114,0394,7895,4965,7685,7846,3776,479

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
4735267267847816869729131,114831
Cash from Investing-469-350-646-428-628-612-688-384-810-784
Cash from Financing-81-79-72-22658-31-340-536-136-178
-15217-8924128-61-190-6167-131

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
54.7254.7252.7452.7452.6852.6852.6852.6852.59
20.6420.7220.6519.4716.5016.3114.9613.9111.82
16.7817.4919.5221.5024.0524.6225.8326.4428.01
Government0.000.000.000.000.000.000.000.000.00
7.867.077.096.296.776.396.516.987.58

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-12
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-12 - Syngene International Limited has informed the Exchange about Schedule of meet

2026-09-11
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-11 - Syngene International Limited has informed the Exchange about Schedule of meet

2026-09-10
General Updates

2026-09-10 - Syngene International Limited has informed the Exchange about the Communication regarding remittance of final dividend for the FY 2025-26.

2026-09-01
Updates

2026-09-01 - Syngene International Limited has informed the Exchange regarding Grant of Performance Share Units under Syngene Long Term Incentive Performance Share Plan (PSP) 2023 (Plan).

2026-08-25
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-25 - Syngene International Limited has informed the Exchange about Schedule of meet

2026-08-24
Acquisition

2026-08-24 - Syngene International Limited has informed the Exchange about Acquisition

2026-08-24
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-24 - Syngene International Limited has informed the Exchange about Schedule of meet

2026-08-10
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-10 - Syngene International Limited has informed the Exchange about Schedule of meet

2026-08-06
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-06 - Syngene International Limited has informed the Exchange about Transcript

News

Recent coverage and analyst commentary for SYNGENE

Loading news…

🤖

AI Stock Analyst

Syngene International Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login